These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 28302487)
1. TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis. Li C; Gao Y; Li Y; Ding D Biochem Biophys Res Commun; 2017 Sep; 491(2):552-557. PubMed ID: 28302487 [TBL] [Abstract][Full Text] [Related]
2. H19 mediates methotrexate resistance in colorectal cancer through activating Wnt/β-catenin pathway. Wu KF; Liang WC; Feng L; Pang JX; Waye MM; Zhang JF; Fu WM Exp Cell Res; 2017 Jan; 350(2):312-317. PubMed ID: 27919747 [TBL] [Abstract][Full Text] [Related]
3. LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway. Xian D; Zhao Y J Cell Mol Med; 2019 Jun; 23(6):3808-3823. PubMed ID: 30997746 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy. Xia C; Li Q; Cheng X; Wu T; Gao P; Gu Y Bioengineered; 2022 Feb; 13(2):2450-2469. PubMed ID: 35014946 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA TUG1 mediates 5-fluorouracil resistance by acting as a ceRNA of miR-197-3p in colorectal cancer. Wang M; Hu H; Wang Y; Huang Q; Huang R; Chen Y; Ma T; Qiao T; Zhang Q; Wu H; Chen Q; Han D; Wang G; Wang X J Cancer; 2019; 10(19):4603-4613. PubMed ID: 31528224 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis. Wang H; Li H; Zhang L; Yang D Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236 [TBL] [Abstract][Full Text] [Related]
7. LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis. Wang Q; Zhang W; Hao S Cell Cycle; 2017 Apr; 16(8):795-801. PubMed ID: 28358263 [TBL] [Abstract][Full Text] [Related]
8. LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis. Yan Z; Bi M; Zhang Q; Song Y; Hong S Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32391554 [TBL] [Abstract][Full Text] [Related]
9. A novel long noncoding RNA, LINC00483 promotes proliferation and metastasis via modulating of FMNL2 in CRC. Yan Y; Wang Z; Qin B Biochem Biophys Res Commun; 2019 Feb; 509(2):441-447. PubMed ID: 30594388 [TBL] [Abstract][Full Text] [Related]
10. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy. Liu K; Yao H; Wen Y; Zhao H; Zhou N; Lei S; Xiong L Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108 [TBL] [Abstract][Full Text] [Related]
11. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer. Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1. Zhu J; Zhang R; Yang D; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Yu T Cell Physiol Biochem; 2018; 51(1):113-128. PubMed ID: 30439718 [TBL] [Abstract][Full Text] [Related]
13. The lncRNA TUG1 promotes cell growth and migration in colorectal cancer via the TUG1-miR-145-5p-TRPC6 pathway. Wang X; Bai X; Yan Z; Guo X; Zhang Y Biochem Cell Biol; 2021 Apr; 99(2):249-260. PubMed ID: 32985219 [TBL] [Abstract][Full Text] [Related]
14. lncRNA MCM3AP-AS1 inhibits the progression of colorectal cancer via the miR-19a-3p/FOXF2 axis. Dai W; Zeng W; Lee D J Gene Med; 2021 Mar; 23(3):e3306. PubMed ID: 33450091 [TBL] [Abstract][Full Text] [Related]
15. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma. Lv J; Kong Y; Gao Z; Liu Y; Zhu P; Yu Z Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis. Han Z; Shi L Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124 [TBL] [Abstract][Full Text] [Related]
17. MiR-505 mediates methotrexate resistance in colorectal cancer by targeting RASSF8. Chen Y; Bian L; Zhang Y J Pharm Pharmacol; 2018 Jul; 70(7):937-951. PubMed ID: 29726011 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα. Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis. Si Z; Yu L; Jing H; Wu L; Wang X J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363 [TBL] [Abstract][Full Text] [Related]
20. Upregulated lncRNA Cyclin-dependent kinase inhibitor 2B antisense RNA 1 induces the proliferation and migration of colorectal cancer by miR-378b/CAPRIN2 axis. Zheng Y; Zeng J; Xia H; Wang X; Chen H; Huang L; Zeng C Bioengineered; 2021 Dec; 12(1):5476-5490. PubMed ID: 34511033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]